Page last updated: 2024-08-23

bucindolol and Hypertension, Pulmonary

bucindolol has been researched along with Hypertension, Pulmonary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belló-Klein, A; Bonetto, JHP; Colombo, R; de Lima-Seolin, BG; Fernandes, RO; Godoy, AEG; Hennemann, MM; Khaper, N; Litvin, IE; Sander da Rosa Araujo, A; Schenkel, PC; Teixeira, RB1
Belló-Klein, A; Bonetto, JHP; Casali, KR; Colombo, R; Donatti, LM; Godoy, AEG; Lima-Seolin, BG; Litvin, IE; Rosa Araujo, ASD; Schenkel, PC; Teixeira, RB1

Other Studies

2 other study(ies) available for bucindolol and Hypertension, Pulmonary

ArticleYear
Bucindolol attenuates the vascular remodeling of pulmonary arteries by modulating the expression of the endothelin-1 A receptor in rats with pulmonary arterial hypertension.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 99

    Topics: Adrenergic beta-Antagonists; Animals; Disease Models, Animal; Echocardiography; Hypertension, Pulmonary; Male; Monocrotaline; Nitric Oxide Synthase Type III; Oxidative Stress; Propanolamines; Pulmonary Artery; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; Vascular Remodeling

2018
Bucindolol improves right ventricle function in rats with pulmonary arterial hypertension through the reversal of autonomic imbalance.
    European journal of pharmacology, 2017, Mar-05, Volume: 798

    Topics: Animals; Autonomic Nervous System; Blood Pressure; Electrocardiography; Heart Ventricles; Hypertension, Pulmonary; Male; Monocrotaline; Propanolamines; Rats; Rats, Wistar; Ventricular Pressure

2017